Regulation of Platelet Function in Older Patients With Atrial Fibrillation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age80+
SponsorUniversity of Michigan
About this trial
The goal of this observational study is to learn about the effects of antiplatelet drugs on patients over the age of 80 with atrial fibrillation. The main question it aims to answer is:
-Is platelet reactivity effectively controlled in patients over the age of 80 diagnosed with atrial fibrillation following the Watchman procedure.
Eligibility criteria
Qualifiers
diagnosed with atrial fibrillation, scheduled for a Watchman Procedure
Disqualifiers
Healthy, taking antiplatelet medication
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov